Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes.

Bostom AG, Maclean AA, Maccubbin D, Tipping D, Giezek H, Hanlon WA.

J Clin Lipidol. 2011 Jul-Aug;5(4):281-7. doi: 10.1016/j.jacl.2011.03.455. Epub 2011 May 13.

PMID:
21784373
2.

Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Maccubbin D, Tipping D, Kuznetsova O, Hanlon WA, Bostom AG.

Clin J Am Soc Nephrol. 2010 Apr;5(4):582-9. doi: 10.2215/CJN.07341009. Epub 2010 Mar 18.

3.

Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.

Yang L, Zhou C, Guo L, Morriello G, Butora G, Pasternak A, Parsons WH, Mills SG, MacCoss M, Vicario PP, Zweerink H, Ayala JM, Goyal S, Hanlon WA, Cascieri MA, Springer MS.

Bioorg Med Chem Lett. 2006 Jul 15;16(14):3735-9. Epub 2006 May 15.

PMID:
16698264
4.

Integrated genomic and proteomic analyses of gene expression in Mammalian cells.

Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE.

Mol Cell Proteomics. 2004 Oct;3(10):960-9. Epub 2004 Jul 6.

5.

Expression and characterization of the chemokine receptor CCR2B from rhesus monkey.

Jin H, Vicario PP, Zweerink H, Goyal S, Hanlon WA, Dorn CP, Mills SG, DeMartino JA, Cascieri MA, Struthers M.

Biochem Pharmacol. 2003 Jul 15;66(2):321-30.

PMID:
12826275
6.

Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38.

Vasselon T, Hanlon WA, Wright SD, Detmers PA.

J Leukoc Biol. 2002 Mar;71(3):503-10.

PMID:
11867688
7.

Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway.

Ayala JM, Goyal S, Liverton NJ, Claremon DA, O'Keefe SJ, Hanlon WA.

J Leukoc Biol. 2000 Jun;67(6):869-75.

PMID:
10857861
8.

L-selectin signaling of neutrophil adhesion and degranulation involves p38 mitogen-activated protein kinase.

Smolen JE, Petersen TK, Koch C, O'Keefe SJ, Hanlon WA, Seo S, Pearson D, Fossett MC, Simon SI.

J Biol Chem. 2000 May 26;275(21):15876-84.

9.

Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration.

Hermanowski-Vosatka A, Mundt SS, Ayala JM, Goyal S, Hanlon WA, Czerwinski RM, Wright SD, Whitman CP.

Biochemistry. 1999 Sep 28;38(39):12841-9.

PMID:
10504254
10.

Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase.

Liverton NJ, Butcher JW, Claiborne CF, Claremon DA, Libby BE, Nguyen KT, Pitzenberger SM, Selnick HG, Smith GR, Tebben A, Vacca JP, Varga SL, Agarwal L, Dancheck K, Forsyth AJ, Fletcher DS, Frantz B, Hanlon WA, Harper CF, Hofsess SJ, Kostura M, Lin J, Luell S, O'Neill EA, O'Keefe SJ, et al.

J Med Chem. 1999 Jun 17;42(12):2180-90.

PMID:
10377223
11.

Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst.

Detmers PA, Zhou D, Polizzi E, Thieringer R, Hanlon WA, Vaidya S, Bansal V.

J Immunol. 1998 Aug 15;161(4):1921-9.

12.

Pkn9, a Ser/Thr protein kinase involved in the development of Myxococcus xanthus.

Hanlon WA, Inouye M, Inouye S.

Mol Microbiol. 1997 Feb;23(3):459-71.

13.

MlpA, a lipoprotein required for normal development of Myxococcus xanthus.

Hanlon WA, Martinez-Canamero M, Inouye M, Inouye S.

J Bacteriol. 1995 Dec;177(24):7150-4.

15.

Potency of antileukoprotease and alpha 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease.

Stolk J, Davies P, Kramps JA, Dijkman JH, Humes JJ, Knight WB, Green BG, Mumford R, Bonney RJ, Hanlon WA.

Am J Respir Cell Mol Biol. 1992 May;6(5):521-6.

PMID:
1316132
16.
17.

The discovery and biologic properties of cephalosporin-based inhibitors of PMN elastase.

Davies P, Ashe BM, Bonney RJ, Dorn C, Finke P, Fletcher D, Hanlon WA, Humes JL, Maycock A, Mumford RA, et al.

Ann N Y Acad Sci. 1991;624:219-29. Review. No abstract available.

PMID:
2064223

Supplemental Content

Loading ...
Support Center